INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/10/2026
Back to search
Official data from USPTO
A
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
05/11/2026
Trademark type
Combined
Nice classes
5, 9, 42
Filing date
10/16/2013
Registration date
10/14/2014
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/09/2025
Last transaction
05/11/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
Schindellegi, CH
Examiner
LAVACHE, LINDA M
Current location
Historical data usage
Mark description
The mark consists of the letter "A" formed by three oblong shapes.
Holders and representatives
Holders
AsedaSciences AG
AsedaSciences AG
AsedaSciences GmbH
Representatives
Jeffery A. Smith MILLEN WHITE ZELANO & BRANIGAN, P.C.
Technical classification
Nice Classes
Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use
Class 9
Measuring apparatus and instrumentsfree flow electrophoresis equipment for protein separation and isolationflow cytometry analyzers for cellular analysis; scientificopticalmeasuringsignaling and checking apparatus and instrumentsfree flow electrophoresis equipment for protein separation and isolationflow cytometers for single cell and population based cellular analysis; measuring and testing machines and instrumentsprotein separation and isolation instrumentsflow cytometerslaboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growingmaintainingevaluating and quality control of cell culturesautomated liquid dispensingprotein separation and isolationsingle cell and population based cellular analysisthe assessment of compound or drug effects on cellular physiology and biologynot for medical purposes; chemistry apparatus and instruments for maintainingevaluating and quality control of cell culturesautomated liquid dispensing of compound preparations and chemical reagentsprotein separation and isolationsingle cell and population based cellular analysisthe assessment of compound or drug effects on cellular physiology and biologynot for medical purpose
Class 42
Scientific research and development; scientific and technological servicesnovel multi-parametric phenotypic screening in the nature of analytical testing services and protein isolation for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical researchdrug discovery and characterization of compound effectscientific research and development relating thereto; Scientific and technological services for scientific analysistesting and research in the fields of pharmaceutical researchdrug discovery and characterization of compound effectprotein separationisolation and characterization; scientific research services; scientific testing and analysis in the fields of pharmaceutical researchdrug discovery and characterization of compound effectprotein separationisolation and characterization; computer-assisted scientific researchtesting and analysis services in the fields of pharmaceutical researchdrug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxinwhere a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical researchdrug discovery and characterization of chemical compoundsprotein separationisolation and characterization; pharmaceutical research and development; Scientific research and scientific and technological servicesanalytical testing and phenotypic screening services in the fields of pharmaceutical researchdrug discovery and characterization of chemical compoundsprotein separationisolation and characterization; scientific laboratory services in the fields of pharmaceutical researchdrug discovery and characterization of chemical compoundsprotein separationisolation and characterization; scientific and technological servicesanalytical testing and phenotypic screening services in the fields of pharmaceutical researchdrug discovery and characterization of chemical compoundsprotein separationisolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research ; provision of scientific information on technological research in the fields of pharmaceutical researchdrug discovery and characterization of chemical compounds; provision of scientific information about industrial analysis and research services in the fields of pharmaceutical researchdrug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and scientific consultancy services in the fields of pharmaceutical researchdrug discovery and characterization of chemical compoundsprotein separationisolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research
Publications
History of USPTO decisions and trademark events.
50 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/09/2025
71AG
REGISTERED-SEC.71 ACCEPTED
09/09/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/13/2025
PC.D
PETITION TO DIRECTOR DISMISSED
08/11/2025
APET
ASSIGNED TO PETITION STAFF
08/11/2025
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
04/14/2025
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
10/14/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
09/29/2023
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
06/07/2023
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
03/27/2023
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
09/20/2022
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/03/2022
INPC
INVALIDATION PROCESSED
08/03/2022
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
04/30/2022
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
08/30/2021
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
08/30/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/27/2021
ES75
TEAS SECTION 71 & 15 RECEIVED
04/14/2021
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
10/14/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/24/2015
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/11/2015
FIMP
FINAL DISPOSITION PROCESSED
03/11/2015
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/14/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2014
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/31/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/29/2014
PUBO
PUBLISHED FOR OPPOSITION
07/29/2014
GPNX
NOTIFICATION PROCESSED BY IB
07/24/2014
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/09/2014
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
07/09/2014
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/09/2014
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/26/2014
ALIE
ASSIGNED TO LIE
06/25/2014
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/09/2014
XAEC
EXAMINER'S AMENDMENT ENTERED
06/09/2014
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/09/2014
GNEA
EXAMINERS AMENDMENT E-MAILED
06/09/2014
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/09/2014
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/04/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/04/2014
RFNT
REFUSAL PROCESSED BY IB
02/22/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/06/2014
RFRR
REFUSAL PROCESSED BY MPU
02/06/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/06/2014
CNRT
NON-FINAL ACTION WRITTEN
02/05/2014
DOCK
ASSIGNED TO EXAMINER
01/31/2014
MAFR
APPLICATION FILING RECEIPT MAILED
12/17/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/13/2013
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/12/2013
Continuous trademark protection
Get notified about every new filing that threatens A or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.